Naoya Yamazaki

75PUBLICATIONS
204CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyMolecular targetsEpidemiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Mar 27, 2026
Docetaxel for Pembrolizumab-Refractory Recurrent Basal Cell Carcinoma.

Yoshiki Sakai, Dai Ogata, Michitoshi Kurisaki

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Jan 15, 2026
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.

Reinhard Dummer, Shibing Deng, Tao Xie

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Dec 05, 2025
Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study.

Akihiro Ishiguro, Dai Ogata, Koshiro Ishiyama

|Oct 28, 2025
Response to Crizotinib in ROS1 Fusion-Positive Metastatic Angiosarcoma of the Scalp: A Case Report.

Yuichi Nakayama, Dai Ogata, Eiji Nakano

Pageof 13

Frequent Collaborators

42 joint publications

Kenjiro Namikawa

28 joint publications

Dai Ogata

24 joint publications

Eiji Nakano

7 joint publications

Yusuke Muto